Previous close | 41.00 |
Open | 40.85 |
Bid | 40.80 x 200 |
Ask | 40.87 x 200 |
Day's range | 40.39 - 41.07 |
52-week range | 35.62 - 67.66 |
Volume | |
Avg. volume | 433,959 |
Market cap | 1.995B |
Beta (5Y monthly) | 0.84 |
PE ratio (TTM) | 15.70 |
EPS (TTM) | 2.60 |
Earnings date | 07 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 63.25 |
Amphastar Pharmaceuticals, Inc. ( NASDAQ:AMPH ) shareholders might be concerned after seeing the share price drop 26...
The latest trading day saw Amphastar Pharmaceuticals (AMPH) settling at $41.52, representing a -1% change from its previous close.
The average brokerage recommendation (ABR) for Amphastar (AMPH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?